(Q36586942)

15 August 2017

1 reference

title

Therapeutic targeting of molecules involved in leukocyte-endothelial cell interactions (English)

1 reference

15 August 2017

0 references

Nicole C Kaneider

1

1 reference

15 August 2017

Andrew J Leger

series ordinal

2

1 reference

15 August 2017

Athan Kuliopulos

series ordinal

3

1 reference

15 August 2017

language of work or name

English

0 references

publication date

5 September 2006

1 reference

15 August 2017

1 reference

15 August 2017

273

1 reference

15 August 2017

19

1 reference

15 August 2017

4416-4424

1 reference

Acquisition of selectin binding and peripheral homing properties by CD4(+) and CD8(+) T cells

15 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2006.05441.X

Migratory properties of naive, effector, and memory CD8(+) T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2006.05441.X

Origins and functions of B-1 cells with notes on the role of CD5

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2006.05441.X

Leukocyte and endothelial cell adhesion molecules as targets for therapeutic interventions in inflammatory disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2006.05441.X

High affinity type I interleukin 1 receptor antagonists discovered by screening recombinant peptide libraries

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2006.05441.X

Statins reduce inflammation in atheroma of nonhuman primates independent of effects on serum cholesterol

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2006.05441.X

Selectins: lectins that initiate cell adhesion under flow

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2006.05441.X

Design and synthesis of sialyl Lewis(x) mimics as E- and P-selectin inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2006.05441.X

Therapeutic antagonists and conformational regulation of integrin function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2006.05441.X

Integrins: versatility, modulation, and signaling in cell adhesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2006.05441.X

The effect of blockade of the CD11/CD18 integrin receptor on infarct size in patients with acute myocardial infarction treated with direct angioplasty: the results of the HALT-MI study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2006.05441.X

Use of anti-ICAM-1 therapy in ischemic stroke: results of the Enlimomab Acute Stroke Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2006.05441.X

A controlled trial of natalizumab for relapsing multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2006.05441.X

Natalizumab for active Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2006.05441.X

Treatment of ulcerative colitis with a humanized antibody to the alpha4beta7 integrin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2006.05441.X

Identification of a potent, selective non-peptide CXCR2 antagonist that inhibits interleukin-8-induced neutrophil migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2006.05441.X

Prevention of lung reperfusion injury in rabbits by a monoclonal antibody against interleukin-8.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2006.05441.X

Noncompetitive allosteric inhibitors of the inflammatory chemokine receptors CXCR1 and CXCR2: prevention of reperfusion injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2006.05441.X

CCR1+/CCR5+ mononuclear phagocytes accumulate in the central nervous system of patients with multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2006.05441.X

CCR1-specific non-peptide antagonist: efficacy in a rabbit allograft rejection model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2006.05441.X

A non-peptide functional antagonist of the CCR1 chemokine receptor is effective in rat heart transplant rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2006.05441.X

Immune cell migration in inflammation: present and future therapeutic targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2006.05441.X

The immune modulator FTY720 targets sphingosine 1-phosphate receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2006.05441.X

The immunomodulator FTY720 interferes with effector functions of human monocyte-derived dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2006.05441.X

Activation and inhibition of G protein-coupled receptors by cell-penetrating membrane-tethered peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2006.05441.X

Pepducin-based intervention of thrombin-receptor signaling and systemic platelet activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2006.05441.X

Blocking the protease-activated receptor 1-4 heterodimer in platelet-mediated thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2006.05441.X

10.1111/J.1742-4658.2006.05441.X

21 January 2018

Identifiers

DOI

1 reference

15 August 2017

1 reference